Banque Pictet & Cie’s Bristol-Myers Squibb BMY Stock Holding History

Banque Pictet & Cie’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,456	Closed	-$2.18M	–	399
2025 Q4	$2.18M	Sell	40,456 -1,322	-3%	-$63.6K	0.01%	207
2025 Q3	$1.88M	Buy	+41,778	New	+$1.95M	0.01%	223
2024 Q2	–	Sell	-95,952	Closed	-$5.2M	–	305
2024 Q1	$5.2M	Sell	95,952 -1,415	-1%	-$72.1K	0.05%	147
2023 Q4	$5M	Buy	97,367 +56,157	+136%	+$2.95M	0.04%	155
2023 Q3	$2.39M	Hold	41,210	–	–	0.03%	194
2023 Q2	$2.64M	Hold	41,210	–	–	0.02%	218
2023 Q1	$2.86M	Hold	41,210	–	–	0.03%	227
2022 Q4	$2.97M	Hold	41,210	–	–	0.03%	234
2022 Q3	$2.93M	Buy	41,210 +34,779	+541%	+$2.52M	0.03%	237
2022 Q2	$495	Buy	6,431 +400	+7%	+$30.5K	﹤0.01%	518
2022 Q1	$440K	Sell	6,031 -108,065	-95%	-$7.26M	﹤0.01%	538
2021 Q4	$7.11M	Buy	114,096 +73,012	+178%	+$4.28M	0.05%	176
2021 Q3	$2.43M	Sell	41,084 -1,205	-3%	-$79.4K	0.03%	186
2021 Q2	$2.83M	Sell	42,289 -7,069	-14%	-$461K	0.03%	180
2021 Q1	$3.12M	Sell	49,358 -80,895	-62%	-$5.03M	0.04%	173
2020 Q4	$8.08M	Buy	130,253 +1,012	+0.8%	+$62.2K	0.11%	98
2020 Q3	$7.79M	Sell	129,241 -5,219	-4%	-$314K	0.12%	95
2020 Q2	$7.91M	Buy	134,460 +900	+0.7%	+$53.8K	0.13%	94
2020 Q1	$7.45M	Sell	133,560 -10,101	-7%	-$617K	0.15%	83
2019 Q4	$9.22M	Buy	+143,661	New	+$8.23M	0.16%	89
2018 Q2	–	Sell	-12,100	Closed	-$765K	–	350
2018 Q1	$765K	Buy	12,100 +600	+5%	+$38.6K	0.02%	256
2017 Q4	$705K	Sell	11,500 -9,350	-45%	-$585K	0.01%	258
2017 Q3	$1.33M	Buy	20,850 +10,000	+92%	+$584K	0.03%	228
2017 Q2	$605K	Sell	10,850 -50,120	-82%	-$2.73M	0.01%	282
2017 Q1	$3.32M	Sell	60,970 -5,480	-8%	-$301K	0.08%	154
2016 Q4	$3.88M	Sell	66,450 -1,900	-3%	-$104K	0.1%	119
2016 Q3	$3.69M	Buy	68,350 +53,100	+348%	+$3.41M	0.1%	121
2016 Q2	$1.12M	Hold	15,250	–	–	0.03%	207
2016 Q1	$974K	Buy	15,250 +7,800	+105%	+$492K	0.03%	209
2015 Q4	$512K	Sell	7,450 -200	-3%	-$13.2K	0.01%	242
2015 Q3	$453K	Buy	+7,650	New	+$485K	0.01%	269
2015 Q2	–	Sell	-11,800	Closed	-$761K	–	338
2015 Q1	$761K	Hold	11,800	–	–	0.02%	280
2014 Q4	$697K	Sell	11,800 -22,512	-66%	-$1.27M	0.02%	287
2014 Q3	$1.76M	Sell	34,312 -70,967	-67%	-$3.54M	0.05%	194
2014 Q2	$5.11M	Buy	105,279 +66,360	+171%	+$3.27M	0.13%	131
2014 Q1	$2.02M	Sell	38,919 -72,105	-65%	-$3.84M	0.06%	174
2013 Q4	$5.9M	Buy	+111,024	New	+$5.66M	0.17%	100

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banque Pictet & Cie's BMY Position: Q1 2026 in Review

Banque Pictet & Cie sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 40,456 shares — an estimated $2.18M sold.

Banque Pictet & Cie first reported a position in BMY in Q4 2013 and held it in 37 quarters. The position peaked at $9.22M in Q4 2019. 2,527 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Banque Pictet & Cie reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Banque Pictet & Cie sold 40,456 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.18M.
Banque Pictet & Cie first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 37 quarters.
Banque Pictet & Cie's Bristol-Myers Squibb position peaked at $9.22M in Q4 2019.
2,527 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.